The social benefits of private infectious disease-risk mitigation

Theoretical Ecology

Volumn 8, Issue 4, 2015, Pages 467-479

  Morin, Benjamin R ^a,b,c   Perrings, Charles ^b   Kinzig, Ann ^a,b   Levin, Simon ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

Affinity based mixing; Disease risk mitigation; Social value of private action

Indexed keywords

COST; EPIDEMIC; INFECTIOUS DISEASE; RISK ASSESSMENT;

EID: 84953837755     PISSN: 18741738     EISSN: 18741746     Source Type: Journal    
DOI: 10.1007/s12080-015-0262-z     Document Type: Article

References (54)

1. Albarracín D, Gillette JC, Earl AN, Glasman LR, Durantini MR et al (2005) A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic. Psychol Bull 131:856
2. Andre F, Booy R, Bock H, Clemens J, Datta S et al (2008) Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 86:140–146
3. Auld MC (2003) Choice, beliefs, and infectious disease dynamics. J Health Econ 22(3):361-377
4. Barrett S (2003) Environment and statecraft: the strategy of environmental treaty-making. Oxford University Press, Oxford
5. Barrett S, Hoel M (2007) Optimal disease eradication. Environ Develop Econom 12:627–652
6. Bauch CT, Earn DJD (2004) Vaccination and the theory of games. Proc Natl Acad Sci 101:13391–13394
7. Blank PR, Schwenkglenks M, Szucs TD (2008) Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 8:272
8. Blythe S, Castillo-Chavez C, Palmer J, Cheng M (1991) Toward a unified theory of sexual mixing and pair formation. Math Biosci 107:379–405
9. Boulier BL, Satta TS, Goldfarb RS (2007) Vaccination externalities. BE J Econ Analys Poli 7(1):
10. Bridges C, Thompson WW, Meltzer MI et al (2000) Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284:1655–1663
11. Busenberg S, Castillo-Chavez C (1991) A general solution of the problem of mixing of subpopulations and its application to risk- and age structured epidemic models for the spread of AIDS. Math Med Biol 8.1:1-29.
12. Castillo-Chavez C, Busenberg S, Gerow K (1991) Pair formation in structured populations. Diff Equat Appl Biol Phys Eng:47–65
13. Cauchemez S, Ferguson NM, Wachtel C, Tegnell A, Saour G et al (2009) Closure of schools during an influenza pandemic. Lancet Infect Dis 9:473–481
14. Chowell G, Castillo-Chavez C, Fenimore PW, Kribs-Zaleta C, Arriola L et al (2004a) Model parameters and outbreak control for SARS. Emerg Infect Dis 10:1258–1263
15. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM (2004b) The basic reproductive number of Ebola and the effects of public health measure: the cases of Congo and Uganda. J Theor Biol 299:119–126
16. Chowell G, Vibound C, Wang X, Bertozzi SM, Miller MA (2009) Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. Pub Lib Sci ONE 4:e8164
17. Fenichel E (2013) Economic considerations for social distancing and behavioral based policies during an epidemic. J Health Econ 32:440–451
18. Fenichel E, Horan R (2007) Jointly-determined ecological thresholds and economics trade-offs in wildlife disease management. Nat Resour Model 20:511–547
19. Fenichel EP, Horan RD, Hickling GJ (2010) Management of infectious wildlife diseases: bridging conventional and bioeconomic approaches. Ecol Appl 20:903–914
20. Fenichel EP, Castillo-Chavez C, Ceddia MG, Chowell G, Gonzalez Parra PA et al (2011) Adaptive human behavior in epidemiological models. Proc Natl Acad Sci 108:6306–6311
21. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC et al (2006) Strategies for mitigating an influenza pandemic. Nature 442:448–452
22. Geoffard P-Y, Philipson T (1996) Rational epidemics and their public control. Int Econom Rev 37:603–624
23. Gersovitz M, Hammer JS (2003) Infectious diseases, public policy, and the marriage of economics and epidemiology. World Bank Res Observ 18:129–157
24. Gersovitz M, Hammer JS (2004) The economical control of infectious diseases. Econom J 114:1–27
25. Gostin LO, Lucey D, Phelan A (2014) The Ebola epidemic: a global health emergency. JAMA 312:1095–1096
26. Gross T, D’Lima C, Blasius B (2006) Epidemic dynamics on an adaptive network. Phys Rev Lett 96:20871
27. Gupta AG, Moyer CA, Stern DT (2005) The economic impact of quarantine: SARS in Toronto as a case study. J Infect 50:386–393
28. Gurarie E, Ovaskainen O (2013) Towards a general formalization of encounter rates in ecology. Theor Ecol 6:189–202
29. Hadeler KP (2012) Pair formation. J Math Biol 64:613–645
30. Hadeler KP, Castillo-Chavez C (1995) A core group model for disease transmission. Math Biosci 128:41–55
31. Horan RD, Fenichel EP, Melstrom RT (2011) Wildlife disease bioeconomics. Int Rev Environ Resour Econom 5:23–61
32. Hyman JM, Li J (1997) Behavior changes in SIS STD models with selective mixing. SIAM J Appl Math 57:1082–1094
33. Karlin S (1979) Models of multifactorial inheritence: I, multivariate formualtions and basic convergence results. Theor Popul Biol 15:308–355
34. Khan K, Arino J, Hu W, Raposo P, Sears J et al (2009) Spread of a novel influenza A (H1N1) virus via global airline transportation. New Eng J Med 361:212–214
35. Klepac P, Caswell H (2011) The stage-structured epidemic: linking disease and demography with a multi-state matrix approach model. Theor Ecol 4:301–319
36. Kremer M (1996) Integrating behavioral choice into epidemiological models of AIDS. Quart J Econom 111:549–573
37. Levin S (1995) Grouping in population models. In: Mollison D (ed) Epidemic models: their structure and relation to data. Cambridge University Press, pp 271–278
38. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757
39. Maharaj S, Kleczkowski A (2012) Controlling epidemic spread by social distancing: do it well or not at all. BMC Public Health 12:679–695
40. Morin BR, Perrings C, Levin S, Kinzig A (2014) Disease risk mitigation: the equivalence of two selective mixing strategies on aggregate contact patterns and resulting epidemic spread. J Theor Biol 363:262–270
41. Murray CJL, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349.9063:1436–1442
42. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD et al (2013) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2197–2223
43. Reluga TC (2010) Game theory of social distancing in response to an epidemic. PLoS Comput Biol 6.5:e1000793
44. Rice DP (2000) Cost of illness studies: what is good about them? Inj Prev 6:177–179
45. Sadique M, Edmunds W, Smith R, Meerding W, de Zwart O et al (2007) Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis 13:1307–1313
46. Sadique M, Adams E, Edmunds W (2008) Estimating the costs of school closure for mitigating an influenza pandemic. BMC Public Health 8:135
47. Sander B, Nizam A, Garrison LP, Postma MJ, Halloran ME et al (2009) Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health J Int Soc Pharmacoeconom Outcome Res 12:226–233
48. Sandler T (2004) Global collective action. Cambridge University Press, Cambridge
49. Shim E, Galvani AP (2009) Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS One 4:e5503
50. Springborn M, Costello C, Ferrier P (2010) Optimal random exploration for trade-related non-indigenous. In: Perrings C, Mooney H, Williamson M (eds) Bioinvasions and globalization: ecology, economics, management, and policy. Oxford University Press, Oxford, pp 127–144
51. World Health Organization (2005) International health regulations. World Health Organization, Geneva
52. World Health Organization (2009) Global health risks: mortality and burden of disease attributable to selected major risks. WHO, Geneva
53. World Trade Organization (1995) The WTO agreement on the application of sanitary and phytosanitary measures (SPS agreement). World Trade Organization, Geneva
54. Yorke JA, Hethcote HW, Nold A (1978) Dynamics and control of the transmission of gonorrhea. Sex Transm Dis 5:51–56